Skip to main content

Exagen: Thierry Dervieux

Exagen announced the departure of Thierry Dervieux, its chief scientific officer, effective Dec. 9. The resignation was not a result of disagreement with the company relating to its operations, policies, or practices, the company said in documents filed with the US Securities and Exchange Commission. According to Dervieux's LinkedIn profile, he has been Exagen's CSO and medical director since 2010.